Work

Effect of neoadjuvant treatment with gemcitabine with nab-paclitaxel on SPARC and Ki-67 in patients with resectable pancreatic adenocarcinoma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e15287

Authors: Sarunas Sliesoraitis, Amy L. Collinsworth, Jose Gilberto Trevino, Steven J. Hughes, Robert Zlotecki, Xiaomin Lu, Judith L. Lightsey, Alison Marguerite Ivey, Carmen Joseph Allegra, Ahmad Alkhasawneh, Long H. Dang, Karen Colleen Daily, Kevin Behrns, Chen Liu, Shailendra Chauhan, Neelam Vijay Desai, Thomas J. George

Institutions: University of Florida, University of Florida Health, UF Health Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4244311132

Cites:

Cited by:

Related to: 10